ArticleJournal of diabetes2026
Correlation of Thyroid Hormone Levels and Sensitivity With Metabolic Syndrome in Older Adults.
Article in Journal of diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivePrevious studies have shown that thyroid function is associated with metabolic syndrome (MetS), but this association remains poorly understood in older adults. This study aimed to explore the relationships between thyroid hormone levels and sensitivity with MetS and its components in older adults.
methodsThe 2018 baseline data of the West China Health and Aging Trends study were used. MetS was diagnosed according to the International Diabetes Federation definition. Central thyroid hormone sensitivity was assessed by the TSH Index (TSHI), Thyrotrophic T4 Resistance Index (TT4RI), Thyroid Feedback Quantile-based Index (TFQI), and Parametric TFQI (PTFQI). Peripheral thyroid hormone sensitivity was assessed by the FT3 to FT4 ratio (FT3/FT4 ratio).
resultsA total of 3796 participants were included. The prevalence of MetS was 40.31%. High FT3 levels and FT3/FT4 ratios were associated with abdominal obesity and hypertension; decreased FT3 levels were associated with hyperglycemia, hypertriglyceridemia and low HDL-C; low FT4 levels were associated with abdominal obesity and hypertriglyceridemia; increased TSH, TSHI and TT4RI levels were associated with hypertriglyceridemia and hypertension; and increased TFQI and PTFQI were associated with hypertension (p < 0.05, for all). Increased FT3 (OR = 1.13, 95% CI: 1.05-1.22), TSH (OR = 1.12, 95% CI: 1.04-1.20), TSHI (OR = 1.09, 95% CI: 1.01-1.17), TT4RI (OR = 1.09, 95% CI: 1.01-1.16), FT3/FT4 (OR = 1.25, 95% CI: 1.16-1.35) and low FT4 (OR = 0.87, 95% CI: 0.81-0.94) were associated with MetS.
conclusionThyroid hormone levels are correlated with MetS and its components. Reduced central thyroid hormone sensitivity and increased peripheral thyroid hormone sensitivity are risk factors for MetS in older adults.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.